NovaBridge Biosciences Current Ratio Growth & History (NBP)
NovaBridge Biosciences's current ratio was 8.09 for fiscal 2025.
View full NovaBridge Biosciences company overviewNovaBridge Biosciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 8.09 | −12.81 | −61.30% |
| 2024 | 2024-12-31 | 20.90 | 15.23 | +268.35% |
| 2023 | 2023-12-31 | 5.67 | 0.89 | +18.62% |
| 2022 | 2022-12-31 | 4.78 | −2.88 | −37.58% |
| 2021 | 2021-12-31 | 7.66 | −1.61 | −17.38% |
| 2020 | 2020-12-31 | 9.28 | 6.96 | +300.95% |
| 2019 | 2019-12-31 | 2.31 | — | — |
NovaBridge Biosciences quarterly current ratio
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 7.64 | −15.18 | −66.52% |
| Q4 2025 | 2025-12-31 | 8.09 | −12.81 | −61.30% |
| Q3 2025 | 2025-09-30 | 14.47 | — | — |
| Q2 2025 | 2025-06-30 | 22.82 | — | — |
| Q1 2025 | 2025-03-31 | 22.35 | — | — |
| Q4 2024 | 2024-12-31 | 20.90 | 15.23 | +268.35% |
| Q4 2023 | 2023-12-31 | 5.67 | 0.89 | +18.62% |
| Q4 2022 | 2022-12-31 | 4.78 | −2.88 | −37.58% |
| Q2 2022 | 2022-06-30 | 7.31 | — | — |
| Q4 2021 | 2021-12-31 | 7.66 | −1.61 | −17.38% |
| Q4 2020 | 2020-12-31 | 9.28 | 6.96 | +300.95% |
| Q3 2020 | 2020-09-30 | 9.18 | — | — |
| Q4 2019 | 2019-12-31 | 2.31 | — | — |
NovaBridge Biosciences current ratio trends
Over the last five fiscal years, NovaBridge Biosciences's current ratio decreased from 9.28 to 8.09, a change of −1.19. The latest reported quarter, Q2 2026, shows 7.64.
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NovaBridge Biosciences source filings ↗